EMV Capital plc portfolio company Wanda Health has successfully closed a £1 million fundraising round, achieving a 21.5x increase in fair value since May 2024. The funds will enhance AI-driven disease monitoring, expand its US market presence, and progress FDA regulatory pathways. Wanda Health’s partnership with the COPD Foundation underscores its innovative approach to remote patient monitoring and virtual care, reinforcing its role in delivering transformative healthcare solutions.
The fundraising was led and syndicated by EMV Capital Partners.
Read more here.